Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
12 Results Found
AHA Comments on DEA Proposed Rule on Special Registrations for Telemedicine Prescribing
AHA comments regarding the Drug Enforcement Administration’s proposed rule for Special Registrations for Telemedicine and Limited State Telemedicine Registrations.
DEA, HHS delay implementation of buprenorphine final rule until Dec. 31
The Drug Enforcement Administration and Department of Health and Human Services yesterday announced that the effective date for the final rule regarding telemedicine prescribing of buprenorphine will be further delayed from March 21 to Dec. 31.
AHA comments on DEA proposed rule on special registrations for telemedicine prescribing
The AHA March 18 commented on the Drug Enforcement Administration's proposed rule for special registrations for telemedicine prescribing of controlled substances.
AHA podcast: Bridging Distances with AI and Telemedicine
In this conversation, Dave Newman, M.D., vice president and chief medical officer for virtual care at Sanford Health, discusses how innovative virtual care models and artificial intelligence-powered solutions are breaking down barriers, improving patient outcomes and enhancing provider efficiency.
Bridging Distances with AI and Telemedicine
Sanford Health, America’s largest rural health system, is revolutionizing care delivery with telemedicine and AI.
Telemedicine Prescribing of Controlled Substances
The Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) Jan. 15 released a proposed rule on special registration for prescribing of controlled substances and a final rule on telemedicine prescribing of buprenorphine.
HHS, DEA release rules related to telemedicine prescribing of controlled substances
The Department of Health and Human Services and Drug Enforcement Administration published a series of rules Jan. 15 related to telemedicine prescribing of controlled substances, including a special registration proposed rule and a final rule on telemedicine prescribing of buprenorphine.
Innovative Care: The Value of the Virtual Nurse in a Pediatric Hospital
With a review of evidence and extensive planning, Nemours Children’s Health created an enterprise virtual nursing model. Learn more about the process of introducing the virtual nurse, and how the incorporation of the virtual has positively contributed to outcomes related to nurse and patient satisfaction. (Webinar presented September 11, 2024)
DEA and HHS Extend Waivers Prescribing Controlled Substances through Telemedicine
The Drug Enforcement Administration (DEA) and Department of Health and Human Services (HHS) on Nov. 15 published a rule to extend waiver flexibilities for prescribing controlled substances via telemedicine.
AHA Requests Flexibility Extension on DEA Telemedicine Prescribing
AHA comments to the Drug Enforcement Administration regarding their efforts to support the safe prescribing of controlled substances via telehealth. Indeed, during the COVID-19 public health emergency